Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.45% | 201.80 | 1.2% | $542.05m | |
| GILD | Gilead Sciences, Inc. | -1.21% | 73.27 | 0.9% | $465.10m | |
| BIIB | Biogen Inc. | -2.95% | 320.41 | 1.3% | $380.15m | |
| CELG | Celgene Corporation | -0.65% | 82.41 | 1.2% | $337.48m | |
| ILMN | Illumina, Inc. | -2.60% | 313.10 | 3.5% | $332.96m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.36% | 389.83 | 2.6% | $235.91m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.79% | 175.69 | 1.9% | $230.46m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.53% | 125.89 | 2.0% | $220.48m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.30% | 134.22 | 16.4% | $169.84m | |
| A | Agilent Technologies, Inc. | -1.95% | 64.47 | 1.5% | $159.28m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.58% | 103.22 | 4.4% | $142.60m | |
| LGND | Ligand Pharmaceuticals Incorporated | -4.84% | 187.52 | 23.3% | $115.84m | |
| EXAS | Exact Sciences Corporation | -2.88% | 61.64 | 25.3% | $102.69m | |
| NKTR | Nektar Therapeutics | -2.76% | 48.19 | 5.6% | $101.86m | |
| NBIX | Neurocrine Biosciences, Inc. | -2.24% | 112.01 | 5.1% | $98.21m |
Company Profile
T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection including one colony forming unit per milliliter. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.